An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-05-23
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 15
- Registration Number
- NCT06427369
An Education and Navigation Support Tool to Improve Participation in Care Coordination Among Patients With Locally Advanced, Metastatic and Unresectable Bladder Cancer and Their Caregivers
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-05-16
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 160
- Registration Number
- NCT06414317
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
A Patient Navigation Program for Addressing Disparities in Breast Cancer Care
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-04-05
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 126
- Registration Number
- NCT06350500
- Locations
- 🇺🇸
Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States
Genetically Engineered Cells (EGFRt/19-28z/IL-12 CAR T Cells) for the Treatment of Relapsed or Refractory CD19+ Hematologic Malignancies
Phase 1
Recruiting
- Conditions
- Recurrent Transformed Chronic Lymphocytic LeukemiaRefractory Diffuse Large B-Cell LymphomaRefractory High Grade B-Cell LymphomaRefractory Mantle Cell LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent High Grade B-Cell LymphomaRecurrent Mantle Cell LymphomaRecurrent Follicular LymphomaRefractory Chronic Lymphocytic LeukemiaRefractory Follicular Lymphoma
- Interventions
- Procedure: BiopsyProcedure: Biospecimen CollectionProcedure: Bone Marrow AspirationProcedure: Bone Marrow BiopsyProcedure: Computed TomographyProcedure: EchocardiographyDrug: CyclophosphamideBiological: EGFRt/19-28z/IL-12 CAR T-lymphocytesProcedure: Multigated Acquisition ScanDrug: Fludarabine PhosphateProcedure: LeukapheresisProcedure: Positron Emission Tomography
- First Posted Date
- 2024-04-02
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 54
- Registration Number
- NCT06343376
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Evaluating the Delivery and Effects of THC Vaping Liquids in the Bloodstream
Early Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-03-27
- Last Posted Date
- 2024-03-27
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 60
- Registration Number
- NCT06334016
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence
- First Posted Date
- 2024-03-21
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 150
- Registration Number
- NCT06323044
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
AI Derived Biomarker to Select Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma
- First Posted Date
- 2024-03-20
- Last Posted Date
- 2024-05-06
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 100
- Registration Number
- NCT06320717
- Locations
- 🇺🇸
Good Samaritan University Hospital, West Islip, New York, United States
🇺🇸Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States
Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-03-13
- Last Posted Date
- 2024-08-05
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 21
- Registration Number
- NCT06307548
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-03-12
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 39
- Registration Number
- NCT06306638
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-03-12
- Last Posted Date
- 2024-11-11
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 14
- Registration Number
- NCT06305598
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
© Copyright 2024. All Rights Reserved by MedPath